The antineoplastic effect of statins combined with PLA2G7 impairment was studied in prostate cancer cells to evaluate the potential for repositioning of in vivo compatible drugs developed for other indications towards anti-cancer purposes. Here, PLA2G7 is linked to Familial prostate cancer.